Figure 5.

Rejection without complete resolution, or with an antibody-mediated component, was associated with more graft loss from chronic allograft nephropathy. The figure shows the adjusted associations between rejection in the first 6 months post-transplant and subsequent outcomes, stratified by (A) whether the rejection completely resolved (defined as the return of graft function to prerejection levels or better) and (B) whether AMR was present or not. P values are for the differences in subhazard ratios between resolving and nonresolving rejection.